A growing number of Tesla Cybertruck owners are losing the ability to charge at home due to failures of the truck’s Power Conversion System (PCS), the unit that handles AC charging and steps the ...

Stop-losses work best when placed with intention. Learn structure-based and risk-based strategies that protect capital ...

DragonForce ransomware used a custom malware named 'Backdoor.Turn' to hide command-and-control traffic inside Microsoft Teams relay infrastructure. The backdoor abuses the Traversal Using Relays ...

For those scared of needles but who need GLP-1 receptor agonists to help manage their weight, there might be some good news. Researchers are testing a new oral, small-molecule GLP-1 receptor agonist ...

In SYNCHRONIZE-1, survodutide achieved −12.2% to −13.0% weight loss at 76 weeks versus −5.4% with placebo, with ≥20% loss in 28.5% at 6.0 mg. MRI substudy data showed organ-selective effects: liver ...

What’s one to do with some nice little relays of questionable pinout, and prototyping board? How about a quietly clicky 4-bit counter using relay logic with tons of buttons? The register with LEDs and ...

Eli Lilly on Thursday released results from TRIUMPH-1, its pivotal Phase 3 trial for the experimental obesity drug retatrutide, showing that participants on the highest dose lost an average of 70.3 ...

Eli Lilly said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering significant weight loss across doses. The results bring Lilly one step closer to filing ...

Abstract: The control and protection systems of three-phase induction motors, which are widely employed in industrial settings because of their dependability and effectiveness, are thoroughly examined ...

iPercent body weight reduction with retatrutide 4 mg was a key secondary endpoint. iiThe extension period enrolled 532 participants with BMI ≥35 at baseline who had completed the main 80-week study ...

Retatrutide met primary and key secondary endpoints in a 2339-participant, randomized, double-blind, placebo-controlled phase 3 trial, demonstrating clinically meaningful weight reduction across 4, 9, ...